Drawing for GULDEVRY

USPTO serial 88187138

GULDEVRY

Reviewed by CopyMark Law Group

Reg. 6932891Status 700Registered
Filing date
Status date
Registration date
Dec 27, 2022
Examiner
FATHY, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GULDEVRY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jack Wessel

Jack Wessel Gilead Sciences, Inc.333 LAKESIDE DRIVEFOSTER CITY, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 24, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 24, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 27, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 27, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 21, 2022DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Nov 17, 2022NREVNOTICE OF REVIVAL - E-MAILED—
Nov 17, 2022PG1BPETITION GRANTED - REQUEST TO DELETE 1(B) FILED—
Nov 14, 2022APETASSIGNED TO PETITION STAFF—
Oct 19, 2022EPGSTEAS PETITION TO REVIVE AND REQUEST TO DELETE 1B OR G/S—
Oct 17, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 17, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 12, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Feb 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 2, 2022EX5GSOU EXTENSION 5 GRANTED—
Feb 2, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 26, 2022EXT5SOU EXTENSION 5 FILED—
Jan 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 13, 2021EX4GSOU EXTENSION 4 GRANTED—
Jul 13, 2021EXT4SOU EXTENSION 4 FILED—
Jul 13, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 8, 2021EX3GSOU EXTENSION 3 GRANTED—
Jan 8, 2021EXT3SOU EXTENSION 3 FILED—
Jan 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2020EX2GSOU EXTENSION 2 GRANTED—
Jul 17, 2020EXT2SOU EXTENSION 2 FILED—
Jul 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 29, 2020EXT1SOU EXTENSION 1 FILED—
Jan 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2019ALIEASSIGNED TO LIE—
May 17, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 13, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 13, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 13, 2019CNSLSUSPENSION LETTER WRITTEN—
Feb 13, 2019DOCKASSIGNED TO EXAMINER—
Nov 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance